|
Volumn , Issue , 2013, Pages 257-263
|
Salivary gland cancer: an update on present and emerging therapies
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ONCOPROTEIN;
CARCINOMA, ADENOID CYSTIC;
CARCINOMA, MUCOEPIDERMOID;
CHEMORADIOTHERAPY;
GENETICS;
HUMAN;
MOLECULARLY TARGETED THERAPY;
MORTALITY;
MUTATION;
PATHOLOGY;
PROCEDURES;
PROGNOSIS;
SALIVARY GLAND NEOPLASMS;
TUMOR RECURRENCE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, ADENOID CYSTIC;
CARCINOMA, MUCOEPIDERMOID;
CHEMORADIOTHERAPY;
HUMANS;
MOLECULAR TARGETED THERAPY;
MUTATION;
NEOPLASM RECURRENCE, LOCAL;
ONCOGENE PROTEINS, FUSION;
PROGNOSIS;
SALIVARY GLAND NEOPLASMS;
|
EID: 84979819086
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.1200/EdBook_AM.2013.33.257 Document Type: Review |
Times cited : (43)
|
References (0)
|